U.S. Markets closed

Avid Bioservices, Inc. (CDMO)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
25.94+0.34 (+1.33%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close25.60
Open26.55
Bid23.85 x 1200
Ask26.72 x 1100
Day's Range25.20 - 26.55
52 Week Range6.49 - 27.02
Volume458,538
Avg. Volume582,606
Market Cap1.578B
Beta (5Y Monthly)2.22
PE Ratio (TTM)N/A
EPS (TTM)-0.00
Earnings DateJun 29, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est27.50
  • Hedge Funds Aren’t Crazy About Avid Bioservices, Inc. (CDMO) Anymore
    Insider Monkey

    Hedge Funds Aren’t Crazy About Avid Bioservices, Inc. (CDMO) Anymore

    The financial regulations require hedge funds and wealthy investors that exceeded the $100 million holdings threshold to file a report that shows their positions at the end of every quarter. Even though it isn’t the intention, these filings to a certain extent level the playing field for ordinary investors. The latest round of 13F filings […]

  • Avid Bioservices Announces Appointment of Esther M. Alegria, Ph.D., to Board of Directors
    GlobeNewswire

    Avid Bioservices Announces Appointment of Esther M. Alegria, Ph.D., to Board of Directors

    Former SVP of Global Manufacturing at Biogen Has Nearly 30 Years of Biopharmaceutical Industry ExperienceTUSTIN, Calif., July 01, 2021 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, today announced the appointment of Esther M. Alegria, Ph.D., as an independent me

  • Avid Bioservices, Inc. (CDMO) Q4 2021 Earnings Call Transcript
    Motley Fool

    Avid Bioservices, Inc. (CDMO) Q4 2021 Earnings Call Transcript

    On today's call, we have Nick Green, President and CEO; Dan Hart, Chief Financial Officer; and Timothy Compton, Chief Commercial Officer. Today we will be providing an overview of Avid Bioservices' contract development and manufacturing business, including updates on corporate activities and financial results for the quarter ended April 30th, 2021.